Sherpapak
Payments companies reported to CMS as associated with Sherpapak. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sherpapak, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sherpapak
These are the largest totals companies reported as associated with Sherpapak. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jeffrey Teuteberg | Stanford, CA | Advanced Heart Failure and Transplant Cardiology | $2,248.75 |
| Kiran Dhanireddy | Tampa, FL | Transplant Surgery | $1,509.59 |
| Jon Kobashigawa | Los Angeles, CA | Advanced Heart Failure and Transplant Cardiology | $1,500.00 |
| Rajat Walia | Phoenix, AZ | Pulmonary Disease | $1,227.86 |
| Maziar Khorsandi | Columbus, OH | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $777.54 |
| Reinaldo Rampolla | West Hollywood, CA | Pulmonary Disease | $717.64 |
| Henry Randall | Kansas City, MO | Transplant Surgery | $678.86 |
| Stephanie Chang | New York, NY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $637.17 |
| Michael Smith | Phoenix, AZ | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $614.78 |
| Lara Schaheen | Phoenix, AZ | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $614.78 |
Prescribed Sherpapak?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.